weight loss
- Europe
England to roll out new anti-obesity drug but only for some patients
The drug is expected to cost €381.1 million per year within three years. ADVERTISEMENT The National Health Service (NHS) in…
Read More » - Europe
Eli Lilly shares rise as Zepbound weight-loss test shows solid success
Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The…
Read More » - Europe
Weight-loss drugs like Ozempic may reduce opioid overdose rates
A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication…
Read More » - Europe
Teens on anti-obesity drugs less likely to consider or attempt suicide
Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also…
Read More » - Europe
Novo Nordisk boss in US grilling over prices for weight-loss drugs
Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But…
Read More » - Europe
Severe obesity is rising in the US, according to new research
The rate of severe obesity is about 40 per cent in the US, with women at particularly high risk of…
Read More » - Europe
Weight loss market: Eli Lilly and Novo Nordisk’s rivals muscle in
As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to…
Read More » - Entrepreneurs
This App Takes a Mental Approach to Weight Loss
Disclosure: Our goal is to feature products and services that we think you’ll find interesting and useful. If you purchase…
Read More » - Science
Obesity drug achieves average weight loss of 24 kg in clinical trial
People who had weekly injections of a drug that mimics natural appetite-suppressing hormones lost 22.5 per cent of their body…
Read More »
